
    
      The primary endpoint was percentage reduction in low-density lipoprotein (LDL) cholesterol.
      Secondary endpoints were percentage reduction in other lipids and achievement of â‰¥50%
      reduction in LDL cholesterol. Intention-to-treat analyses were performed.
    
  